Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
PHASE2CompletedINTERVENTIONAL
Enrollment
27
Participants
Timeline
Start Date
December 31, 2004
Primary Completion Date
March 31, 2007
Study Completion Date
April 30, 2013
Conditions
Prostate Cancer
Interventions
DRUG
dutasteride
Oral
Trial Locations (1)
14263-0001
Roswell Park Cancer Institute, Buffalo
All Listed Sponsors
lead
Roswell Park Cancer Institute
OTHER
NCT00403000 - Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | Biotech Hunter | Biotech Hunter